Skip to main content
. 2022 May 31;60(8):1118–1124. doi: 10.1016/j.bjoms.2022.05.009

Table 2.

Cohort characteristics grouped by surgical site infection (SSI), and bivariate and multivariate analyses.

Parameters Total*
(n = 1285)
SSI
(n = 119)
Non-SSI
(n = 1,166)
p value
(OR; 95% CI)
RR
Demographic:
 Female 370 (28.8) 40 (10.8) 330 (89.2) 0.24 (1.28; 0.86 to 1.92) 1.25**
 Males 915 (71.2) 79 (8.6) 836 (91.4)
 Females: case group 74 (5.8) 11 (14.9) 63 (85.1) 0.21 (1.61; 0.76 to 3.39) 1.52**
 Females: control group 296 (23) 29 (9.8) 267 (90.2)
 Age ≥ 60 years 170 (13.2) 82 (48.2) 88 (51.8) < 0.0001 (27.15; 17.4 to 42.36) 14.54**
 Age < 60 years 1,115 (86.8) 37 (3.3) 1,078 (96.7)
 Age ≥ 60 years: case group 34 (2.6) 23 (67.6) 11 (32.4) 0.013 (2.73; 1.23 to 6.04) 1.56**
 Age ≥ 60 years: control group 136 (10.6) 59 (43.4) 77 (56.6)
Clinical:
 Sharp/penetrating trauma 240 (18.7) 22 (9.2) 218 (90.8) 1.0(0.99; 0.61 to 1.6) 0.99
 Blunt trauma 1045 (81.3) 97 (9.3) 948 (90.7)
 Blunt trauma: case group 209 (16.3) 18 (8.6) 191 (91.4) 0.46(1.24; 0.72 to 2.15) 1.22**
 Blunt trauma fracture: control group 836 (65.1) 59 (7.1) 777 (92.9)
 Presence of fracture 135 (10.5) 21 (15.6) 114 (84.4) 0.012(1.98; 1.19 to 3.29) 1.83**
 Soft tissue injury only 1,150 (89.5) 98 (8.5) 1,052 (91.5)
 Presence of fracture: case group 27 (2.1) 12 (44.4) 15 (55.6) < 0.0001 (8.8; 3.17 to 24.42) 5.33**
 Presence of fracture: control group 108 (8.4) 9 (8.3) 99 (91.7)
 Contact with VROs 510 (39.7) 88 (17.3) 422 (82.7) < 0.0001(5; 3.27 to 7.67) 4.31**
 No contact with VROs 775 (60.3) 31 (4) 744 (96)
 Contact with VROs: case group 102 (7.9) 34 (33.3) 68 (66.7) < 0.0001(3.28; 1.99 to 5.41) 2.52**
 Contact with VROs: control group 408 (31.8) 54 (13.2) 354 (86,8)
Operative:
 Fracture repair 135 (10.5) 21 (16.8) 114 (84.4) 0.012(1.98; 1.19 to 3.29) 1.83**
 Simple wound closure 1,150 (89.5) 98 (8.5) 1,052 (91.5)
 Fracture repair: case group 27 (2.1) 12 (44.4) 15 (55.6) < 0.0001(8.8; 3.17 to 24.42) 5.33**
 Fracture repair: control group 108 (8.4) 9 (8.3) 99 (91.7)
 Prolonged antibiotic use 305 (23.7) 95 (31.1) 210 (68.9) < 0.0001(18.02; 11.24 to 28.89) 12.72**
 No prolonged antibiotic use 980 (76.3) 24 (2.4) 956 (97.6)
 Prolonged antibiotic use: case group 61 (4.7) 32 (52.5) 29 (47.5) 0.0001(3.17; 1.78 to 5.65) 2.03**
 Prolonged antibiotic use: control group 244 (19) 63 (25.8) 181 (74.2)
 Hospital stay 418 (32.5) 76 (18.2) 342 (81.8) < 0.0001(4.26; 2.87 to 6.32) 3.67**
 No hospital stay 867 (67.5) 43 (5) 824 (95)
 Hospital stay: case group 257 (20) 49 (19.1) 208 (80.9) 0.6 (1.17; 0.7 to 1.96) 1.14**
 Hospital stay: control group 161 (14.8) 27 (16.8) 134 (83.2)
Overall (whole cohort):
 Case group 257 (20) 49 (19.1) 208 (80.9) < 0.0001 (3.22; 2.17 to 4.78) 2.8**
 Control group 1,028 (80) 70 (6.8) 958 (93.2)

VRO – viral reservoir organ; OR – adjusted odds ratio; 95% CI – 95% confidence interval; RR – relative risk. Categorical data are presented as number (percentage).

*

Percentages in this column were calculated by the total subjects (n = 1,285).

**

Risk factors were determined by relative risk values (RR > 1.0).